A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee
This study is investigating a new medicine, SAR446959, for people who have osteoarthritis in their knee. This is a very early-stage study, meaning it's the very first time this particular medicine is being tried in humans. The main purpose is to carefully check if the medicine is safe for people to take and to see if they experience any uncomfortable side effects, or 'tolerability'. It's not about seeing if the medicine cures osteoarthritis yet, but rather gathering important information about its basic safety profile. Researchers will be looking closely at how the body reacts to the new treatment. Both men and women, aged 18 and older, who have knee osteoarthritis may be able to join this study.
De un vistazo
¿De qué trata este estudio?
This research is focused on osteoarthritis, a common condition that affects millions of people, especially in the knee. Osteoarthritis happens when the protective cartilage on the ends of your bones wears down over time, leading to pain, stiffness, and sometimes swelling. It can make everyday activities like walking or climbing stairs difficult.
Researchers are looking at a new medicine, which has the code name SAR446959. This is a "first-in-human" study, which means it's the very first time this specific medicine is being given to people. Before a new medicine can be used more widely, it has to go through several stages of testing. This initial stage is crucial for understanding how the human body reacts to the medicine.
The main goal of this particular study is to see if SAR446959 is safe for people to take and to understand its *tolerability*. Tolerability just means how well people cope with the medicine and if they experience any side effects. It's not about finding out if it will cure your knee pain yet, but about making sure it's safe enough to continue with further research. This careful first step is vital for developing new and effective treatments in the future.
Puntos clave
- This is a study of a new medicine (SAR446959) for knee osteoarthritis.
- It's the first time this medicine is being tried in humans.
- The main purpose is to check if the medicine is safe and how people tolerate it.
- Both men and women aged 18 and over with knee osteoarthritis may be eligible.
- Participation involves regular clinic visits for monitoring and assessments.
- Puede retirarse del estudio en cualquier momento.
¿Quién puede ser elegible?
To join this study, you generally need to be an adult, aged 18 or older. Whether you are male or female, you could be considered for participation.
The study is specifically looking for people who have osteoarthritis in their knee. This means you would need to have been diagnosed with this condition by a doctor.
There will be other detailed criteria that the study team will need to check to make sure the study is right for you and that taking part would be safe. For example, they might need to know about any other health conditions you have, or any other medicines you are currently taking. This is all to ensure your safety throughout the study.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes 18 años o más?
- Have you been diagnosed with osteoarthritis in your knee?
- Are you able to attend regular clinic appointments?
- Are you willing to potentially receive a new, untested medicine?
- Are you comfortable with regular medical check-ups, including blood tests?
¿En qué consiste la participación?
If you decide to take part in this study, you would first have a screening visit to check if you meet all the requirements. If you do, you would then receive the study medicine, SAR446959. Because this is a very early study, you would likely have regular visits to the clinic so the research team can carefully monitor your health and how you react to the medicine. These visits would involve various checks, such as blood tests, physical examinations, and possibly questionnaires about how you are feeling. The study team will explain exactly how many visits you would need, how long each visit might be, and the total length of time you would be involved in the study. All of this information would be provided before you agree to participate.
Riesgos y beneficios potenciales
Ubicaciones (1)
- —No verificadoAlemania
Preguntas comunes
¿Qué es la osteoartritis?
Osteoarthritis is a common condition where the smooth cartilage in your joints wears down over time, leading to pain, stiffness, and sometimes swelling, often in the knees.
What does 'first-in-human' mean?
It means this is the very first time this experimental medicine, SAR446959, is being given to people, after extensive testing in laboratories.
Will this medicine cure my knee pain?
The main goal of this study is to check for safety and how well people tolerate the medicine, not yet to see if it cures pain. That comes in later stages of research.
What kind of checks will I have during the study?
You would have regular check-ups, which might include blood tests, physical exams, and questions about how you are feeling, to carefully monitor your health.
¿Puedo abandonar el estudio si cambio de opinión?
Yes, you have the right to leave the study at any time, for any reason, without your medical care being affected.
Cómo obtener más información
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.